LISA NEUENFELDT: Open Payments
NPI 1619290673 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,383 in 63 payments from 29 companies in 2025. Trend: 2023 $1,159 · 2024 $1,919 · 2025 $1,383
Food & beverage: $1,383
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 7 | $215 |
| E.R. Squibb & Sons, L.L.C. | 7 | $151 |
| ABBVIE INC. | 5 | $105 |
| Janssen Biotech, Inc. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Daiichi Sankyo Inc. | 3 | $70 |
| Astellas Pharma US Inc | 3 | $69 |
| BeOne Medicines USA, Inc. | 3 | $67 |
| ARRAY BIOPHARMA INC | 3 | $51 |
| Novocure Inc. | 2 | $41 |
Products named: REBLOZYL, OPDIVO, Epkinly, BRUKINSA, BRAFTOVI, Vyloy, RYBREVANT, Enhertu.
Industry payments across FL — which companies pay providers there.
